BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 28058752)

  • 1. ORAI1 Mutations with Distinct Channel Gating Defects in Tubular Aggregate Myopathy.
    Böhm J; Bulla M; Urquhart JE; Malfatti E; Williams SG; O'Sullivan J; Szlauer A; Koch C; Baranello G; Mora M; Ripolone M; Violano R; Moggio M; Kingston H; Dawson T; DeGoede CG; Nixon J; Boland A; Deleuze JF; Romero N; Newman WG; Demaurex N; Laporte J
    Hum Mutat; 2017 Apr; 38(4):426-438. PubMed ID: 28058752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gain-of-function mutations in STIM1 and ORAI1 causing tubular aggregate myopathy and Stormorken syndrome.
    Böhm J; Laporte J
    Cell Calcium; 2018 Dec; 76():1-9. PubMed ID: 30243034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tubular aggregate myopathy and Stormorken syndrome: Mutation spectrum and genotype/phenotype correlation.
    Morin G; Biancalana V; Echaniz-Laguna A; Noury JB; Lornage X; Moggio M; Ripolone M; Violano R; Marcorelles P; Maréchal D; Renaud F; Maurage CA; Tard C; Cuisset JM; Laporte J; Böhm J
    Hum Mutat; 2020 Jan; 41(1):17-37. PubMed ID: 31448844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional analyses of STIM1 mutations reveal a common pathomechanism for tubular aggregate myopathy and Stormorken syndrome.
    Peche GA; Spiegelhalter C; Silva-Rojas R; Laporte J; Böhm J
    Neuropathology; 2020 Dec; 40(6):559-569. PubMed ID: 33073872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRAC channels and disease - From human CRAC channelopathies and animal models to novel drugs.
    Feske S
    Cell Calcium; 2019 Jun; 80():112-116. PubMed ID: 31009822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tubular aggregate myopathy and Stormorken syndrome].
    Böhm J; Laporte J
    Med Sci (Paris); 2018 Nov; 34 Hors série n°2():26-31. PubMed ID: 30418142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silencing of the Ca
    Silva-Rojas R; Pérez-Guàrdia L; Lafabrie E; Moulaert D; Laporte J; Böhm J
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activating mutations in STIM1 and ORAI1 cause overlapping syndromes of tubular myopathy and congenital miosis.
    Nesin V; Wiley G; Kousi M; Ong EC; Lehmann T; Nicholl DJ; Suri M; Shahrizaila N; Katsanis N; Gaffney PM; Wierenga KJ; Tsiokas L
    Proc Natl Acad Sci U S A; 2014 Mar; 111(11):4197-202. PubMed ID: 24591628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STIM1 over-activation generates a multi-systemic phenotype affecting the skeletal muscle, spleen, eye, skin, bones and immune system in mice.
    Silva-Rojas R; Treves S; Jacobs H; Kessler P; Messaddeq N; Laporte J; Böhm J
    Hum Mol Genet; 2019 May; 28(10):1579-1593. PubMed ID: 30576443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A dual mechanism promotes switching of the Stormorken STIM1 R304W mutant into the activated state.
    Fahrner M; Stadlbauer M; Muik M; Rathner P; Stathopulos P; Ikura M; Müller N; Romanin C
    Nat Commun; 2018 Feb; 9(1):825. PubMed ID: 29483506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ORAI1 channel gating and selectivity is differentially altered by natural mutations in the first or third transmembrane domain.
    Bulla M; Gyimesi G; Kim JH; Bhardwaj R; Hediger MA; Frieden M; Demaurex N
    J Physiol; 2019 Jan; 597(2):561-582. PubMed ID: 30382595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gain-of-Function Mutation in STIM1 (P.R304W) Is Associated with Stormorken Syndrome.
    Morin G; Bruechle NO; Singh AR; Knopp C; Jedraszak G; Elbracht M; Brémond-Gignac D; Hartmann K; Sevestre H; Deutz P; Hérent D; Nürnberg P; Roméo B; Konrad K; Mathieu-Dramard M; Oldenburg J; Bourges-Petit E; Shen Y; Zerres K; Ouadid-Ahidouch H; Rochette J
    Hum Mutat; 2014 Oct; 35(10):1221-32. PubMed ID: 25044882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dominant STIM1 mutation causes Stormorken syndrome.
    Misceo D; Holmgren A; Louch WE; Holme PA; Mizobuchi M; Morales RJ; De Paula AM; Stray-Pedersen A; Lyle R; Dalhus B; Christensen G; Stormorken H; Tjønnfjord GE; Frengen E
    Hum Mutat; 2014 May; 35(5):556-64. PubMed ID: 24619930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tubular aggregate myopathy with features of Stormorken disease due to a new STIM1 mutation.
    Noury JB; Böhm J; Peche GA; Guyant-Marechal L; Bedat-Millet AL; Chiche L; Carlier RY; Malfatti E; Romero NB; Stojkovic T
    Neuromuscul Disord; 2017 Jan; 27(1):78-82. PubMed ID: 27876257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. York platelet syndrome is a CRAC channelopathy due to gain-of-function mutations in STIM1.
    Markello T; Chen D; Kwan JY; Horkayne-Szakaly I; Morrison A; Simakova O; Maric I; Lozier J; Cullinane AR; Kilo T; Meister L; Pakzad K; Bone W; Chainani S; Lee E; Links A; Boerkoel C; Fischer R; Toro C; White JG; Gahl WA; Gunay-Aygun M
    Mol Genet Metab; 2015 Mar; 114(3):474-82. PubMed ID: 25577287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STIM1 and ORAI1 mutations leading to tubular aggregate myopathies are sensitive to the Store-operated Ca
    Riva B; Pessolano E; Quaglia E; Cordero-Sanchez C; Bhela IP; Topf A; Serafini M; Cox D; Harris E; Garibaldi M; Barresi R; Pirali T; Genazzani AA
    Cell Calcium; 2022 Jul; 105():102605. PubMed ID: 35636153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ORAI1 inhibition as an efficient preclinical therapy for tubular aggregate myopathy and Stormorken syndrome.
    Silva-Rojas R; Pérez-Guàrdia L; Simon A; Djeddi S; Treves S; Ribes A; Silva-Hernández L; Tard C; Laporte J; Böhm J
    JCI Insight; 2024 Mar; 9(6):. PubMed ID: 38516893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complex phenotypes associated with STIM1 mutations in both coiled coil and EF-hand domains.
    Harris E; Burki U; Marini-Bettolo C; Neri M; Scotton C; Hudson J; Bertoli M; Evangelista T; Vroling B; Polvikoski T; Roberts M; Töpf A; Bushby K; McArthur D; Lochmüller H; Ferlini A; Straub V; Barresi R
    Neuromuscul Disord; 2017 Sep; 27(9):861-872. PubMed ID: 28624464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium Dyshomeostasis in Tubular Aggregate Myopathy.
    Lee JM; Noguchi S
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27879676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of STIM1/ORAI1-mediated store-operated Ca
    Michelucci A; García-Castañeda M; Boncompagni S; Dirksen RT
    Cell Calcium; 2018 Dec; 76():101-115. PubMed ID: 30414508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.